Ubrelvy Tablet
Product Images NDC 0023-6498

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Ubrelvy (NDC 0023-6498). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Following Structural Formula For Ubrelvy Is Ubrogepant, A Calcitonin Gene-related Peptide (cgrp) Receptor Antagonist. The Chemical Name Of Ubrogepant Is (3's)-n-((3s,5s,6r)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxamide. (Ubrelvy 01)

FDA Label Image

Figure 1: Percentage Of Patients Achieving Pain Freedom Within 2 Hours In Pooled Studies 1 And 2 (Ubrelvy 02)

The text describes a graph displaying the percentage of individuals achieving pain freedom over time in hours from dose. The graph includes three data points at 60%, 80%, and 100%, as well as a fourth point labeled "409". The x-axis represents time in hours from the dose, ranging from 1 hour to 15 hours. There are two lines on the graph representing the medications UBRELVY 100 mg and UBRELVY 50 mg, as well as a line for the placebo group.*

FDA Label Image

Figure 2: Percentage Of Patients Achieving Mbs Freedom Within 2 Hours In Pooled Studies 1 And 2 (Ubrelvy 03)

This appears to be a chart showing the effectiveness of UBRELVY, a medication available in 50 mg and 100 mg doses, compared to a placebo. The chart shows the percentage of people achieving a desired outcome over time after taking the medication or placebo. However, without knowing the desired outcome or more context, it's difficult to provide a more detailed description.*

FDA Label Image

Allergan (Ubrelvy 05)

FDA Label Image

Ndc 0023-6498-02ubrelvy(ubrogepant) Tablet50 mgrx Onlycontains 1 Tablet (Ubrelvy 06)

This is a description of UBRELVY® medication, which comes in tablets format of 50 mg of brogepant. It warns to keep the medication out of reach of children and provides storage instructions (between 20°C and 25°C). The text also indicates to refer to the package insert for more information and mentions a lot number of MY 12345.*

FDA Label Image

Ndc 0023-6498-02ubrelvy(ubrogepant) Tablet50 mgrx Onlycontains 1 Tablet (Ubrelvy 07)

UBRELVY is a medication available in tablet form, containing the active ingredient Ubrogepant. No additional information is available due to the limited text provided.*

FDA Label Image

Ndc 0023-6498-10ubrelvy(ubrogepant) Tablets50 mgrx Onlycontains 10 Tablets (Ubrelvy 08)

FDA Label Image

Ndc 0023-6498-16ubrelvy(ubrogepant) Tablets50 mgrx Onlycontains 16 Tablets (Ubrelvy 09)

UBRELVY is a type of medication that comes in tablet form and contains ubrogepant. Unfortunately, the results are incomplete and not correct, so additional information cannot be provided.*

FDA Label Image

Ndc 0023-6498-30ubrelvy(ubrogepant) Tablets50 mgrx Onlycontains 30 Tablets (Ubrelvy 0a)

UBRELVY® is a prescription medication available in 100 mg tablets. It is manufactured by Forest Laboratories and should be stored between 20°C and 25°C (68°F and 77°F). The LOT number for this medication is 12345.*

FDA Label Image

Ndc 0023-6501-02ubrelvy(ubrogepant) Tablet100 mgrx Onlycontains 1 Tablet (Ubrelvy 0b)

FDA Label Image

Ndc 0023-6501-02ubrelvy(ubrogepant) Tablet100 mgrx Onlycontains 1 Tablet (Ubrelvy 0c)

FDA Label Image

Ndc 0023-6501-10ubrelvy(ubrogepant) Tablets100 mgrx Onlycontains 10 Tablets (Ubrelvy 0d)

This is not-available as the text only contains jumbled words and characters.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.